Search for Clinical Trial Results

Sponsored By

Cell Transformation, Neoplastic - 8 Studies Found

Status Study
Completed Study Name: Gene Expression in Samples From Patients With T-Cell Acute Lymphoblastic Leukemia
Condition:
  • Leukemia
  • Lymphoma

Date: 2012-01-26
Interventions:
  • Genetic: gene expression analysis
  • Other: l
Active, not recruiting Study Name: Genetic Analysis Using Blood or Bone Marrow From Participants With Neuroblastoma or Noncancerous Conditions
Condition: Neuroblastoma
Date: 2007-02-15
Interventions:
  • Genetic: gene mapping
  • Genetic: polymorphis
Terminated Study Name: Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer
Condition:
  • Non-melanomatous Skin Cancer
  • Pancreatic Cancer
  • Small Intes
    Date: 2009-05-09
    Interventions:
    • Genetic: in situ hybridization

Completed Study Name: Biomarkers in Tissue Samples From Young Patients With Liver Cancer
Condition:
  • Childhood Hepatoblastoma
  • Stage I Childhood Liver Cancer
  • St
    Date: 2011-04-15
    Interventions:
    • Genetic: RNA analysis
    • Genetic: gene expres
Active, not recruiting Study Name: Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney Cancer
Condition:
  • Adult Solid Neoplasm
  • Hormone-Resistant Prostate Cancer
  • Rec
    Date: 2011-11-23
    Interventions:
    • Drug: Akt Inhibitor MK2206 Giv
Completed Study Name: Immunotherapy for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Blast Phase Chronic Myelogenous Leukemia (BP CML), and Myelodysplastic Syndrome (MDS) Relapse After Allogeneic Transplantation
Condition: Leukemia
Date: 2007-10-22
Interventions:
  • Biological: GM-CSF Dosing sche
Active, not recruiting Study Name: A Phase II Study to Evaluate the Efficacy and the Safety of Flumatinib in CML-AP or CML-BP Patients
Condition: Chronic Myelogenous Leukemia
Date: 2015-07-26
Interventions: Drug: Flumatinib mesylate tablet 600 mg qd Flumatinib mesylate tablet 600 mg qd in CML-AP or CML-BP pati
Recruiting Study Name: Nilotinib-Chemotherapy in CML Myeloid BP or Bcr-abl(+) AML
Condition:
  • Chronic Myeloid Leukemia in Myeloid Blast Crisis
  • Untreated Adult Acute Myeloid Leukemia

    • Date: 2012-09-11
    Interventions: Drug: Nilotinib+AD induction • Post-remission consol